AUC (95% CI) | Sensitivity (%) | Specificity (%) | PPV (%) | NPV (%) | |
≤24 hours (n=2028 observations; call to physician=219 (11%) observations) | |||||
PAWS | 0.74 (0.70 to 0.78) | 76 | 50 | 15 | 95 |
PEWS | 0.74 (0.70 to 0.78) | 77 | 48 | 15 | 95 |
Bedside PEWS | 0.76 (0.72 to 0.80) | 81 | 46 | 15 | 95 |
≤36 hours (n=2550 observations; physician call=245 (10%) observations) | |||||
PAWS | 0.74 (0.70 to 0.77) | 72 | 60 | 16 | 95 |
PEWS | 0.75 (0.71 to 0.78) | 78 | 53 | 15 | 96 |
Bedside PEWS | 0.75 (0.72 to 0.79) | 79 | 53 | 15 | 96 |
≤48 hours (n=3156 observations; call to physician=267 (8%) observations) | |||||
PAWS | 0.73 (0.70 to 0.77) | 64 | 71 | 17 | 96 |
PEWS | 0.75 (0.72 to 0.79) | 73 | 63 | 15 | 96 |
Bedside PEWS | 0.75 (0.72 to 0.79) | 71 | 65 | 15 | 96 |
≤6 day (n=4556 observations; call to physician=315 (7%) observations) | |||||
PAWS | 0.71 (0.68 to 0.74) | 55 | 76 | 14 | 96 |
PEWS | 0.75 (0.72 to 0.78) | 58 | 75 | 15 | 96 |
Bedside PEWS | 0.75 (0.72 to 078) | 66 | 69 | 13 | 96 |
Performances of scores were calculated from a predictive equation derived on the development sample; sensitivity and specificity were calculated using thresholds measured on the development sample.
AUC, area under the receiver-operating curve; Bedside PEWS, Bedside Paediatric Early Warning System; PPV, positive predictive value; NPV, negative predictive value; PAWS, Paediatric Advanced Warning Score; PEWS, Paediatric Early Warning Score.